Fast-growing oligodendrogliomas are aggressive tumors-the real life biomarker?
作者信息
Geurts Marjolein, van den Bent Martin J
机构信息
Brain Tumor Center at Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
出版信息
Neuro Oncol. 2020 Jul 7;22(7):907-908. doi: 10.1093/neuonc/noaa097.
Abstract
摘要
相似文献
1
Fast-growing oligodendrogliomas are aggressive tumors-the real life biomarker?
Neuro Oncol. 2020 Jul 7;22(7):907-908. doi: 10.1093/neuonc/noaa097.
2
Oligodendrogliomas.
Neurol Clin. 1995 Nov;13(4):861-73.
3
[Reappraisal of the Sainte-Anne Hospital classification of oligodendrogliomas in view of retrospective studies].
Neurochirurgie. 2005 Sep;51(3-4 Pt 2):247-53. doi: 10.1016/s0028-3770(05)83485-x.
4
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology.
Acta Neuropathol. 2011 Feb;121(2):241-52. doi: 10.1007/s00401-010-0770-2. Epub 2010 Nov 11.
5
Clinical significance of ABCA2' a possible molecular marker for oligodendrogliomas.
Neurosurgery. 2007 Apr;60(4):707-14; discussion 714. doi: 10.1227/01.NEU.0000255395.15657.06.
6
Oligodendroglioma: pathology and molecular biology.
Surg Neurol. 2002 Aug;58(2):111-7; discussion 117. doi: 10.1016/s0090-3019(02)00751-6.
7
Clinical significance of chromosome 1p/19q loss of heterozygosity and Sox17 expression in oligodendrogliomas.
Int J Clin Exp Pathol. 2014 Dec 1;7(12):8609-15. eCollection 2014.
8
p53 immunoreactivity in oligodendrogliomas.
J Neurooncol. 1994;22(1):1-6. doi: 10.1007/BF01058349.
9
Oligodendrogliomas in pediatric and teenage patients only rarely exhibit molecular markers and patients have excellent survivals.
J Neurooncol. 2018 Sep;139(2):307-322. doi: 10.1007/s11060-018-2890-9. Epub 2018 May 14.
10
Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma.
Childs Nerv Syst. 2015 Jun;31(6):885-91. doi: 10.1007/s00381-015-2684-8. Epub 2015 Mar 27.
引用本文的文献
1
Expression and prognostic value of SEC13 across multiple tumour types and its association with the regulation by Pulsatilla chinensis: a multi-omics and Mendelian Randomization Study.
Discov Oncol. 2025 Jul 17;16(1):1353. doi: 10.1007/s12672-025-03148-0.
本文引用的文献
1
Imaging growth as a predictor of grade of malignancy and aggressiveness of IDH-mutant and 1p/19q-codeleted oligodendrogliomas in adults.
Neuro Oncol. 2020 Jul 7;22(7):993-1005. doi: 10.1093/neuonc/noaa022.
2
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas.
Neuro Oncol. 2019 Dec 17;21(12):1519-1528. doi: 10.1093/neuonc/noz124.
3
Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways.
NPJ Precis Oncol. 2018 Nov 6;2:24. doi: 10.1038/s41698-018-0067-9. eCollection 2018.
4
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma.
J Neurooncol. 2018 Sep;139(2):349-357. doi: 10.1007/s11060-018-2867-8. Epub 2018 Apr 16.
5
Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.
Neuro Oncol. 2018 Jan 10;20(1):66-77. doi: 10.1093/neuonc/nox132.
6
The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
Neuro Oncol. 2018 Jan 10;20(1):103-112. doi: 10.1093/neuonc/nox176.
7
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
J Neurooncol. 2017 Nov;135(2):273-284. doi: 10.1007/s11060-017-2570-1. Epub 2017 Sep 7.
8
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHO.
Acta Neuropathol. 2015 Jun;129(6):867-73. doi: 10.1007/s00401-015-1438-8. Epub 2015 May 12.
9
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.
Neuro Oncol. 2014 Sep;16(9):1244-54. doi: 10.1093/neuonc/nou047. Epub 2014 Apr 9.
10
Velocity of tumor spontaneous expansion predicts long-term outcomes for diffuse low-grade gliomas.
Neuro Oncol. 2013 May;15(5):595-606. doi: 10.1093/neuonc/nos331. Epub 2013 Feb 7.
Zotero 插件